Castle Biosciences, Inc. (CSTL)
NASDAQ · Services · Services-medical laboratories
CSTL price, last 12 months
Key stats
- Previous close
- $35.19
- Open
- $35.19
- Day range
- $34.44 – $36.12
- 52-week range
- $17.72 – $44.28
- Volume
- 437.7K
- Avg volume (20 days)
- 337.2K
- Market cap
- $1.1B
Performance
Technicals and fundamentals
About Castle Biosciences, Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.
- Sector
- Services
- Industry
- Services-medical laboratories
- Listed on
- NASDAQ
- Market cap
- $1.1B